|
|
|
|
|
|
|
|
|
|
Cancer World
Targeted drugs can result in a variety of skin toxicities that are unpleasant for patients and, if unattended to, can lead them to stop taking their drug as prescribed. Effective teamwork is required to ensure symptoms are identified and managed.
The European School of Oncology presents weekly e-grandrounds which offer participants the chance to discuss a range of cutting-edge issues with leading European experts. One of these is selected for publication in each issue of Cancer World.
In this issue Christine Boers-Doets, from the department of Clinical Oncology at Leiden University Medical Centre in The Netherlands, reviews the occurrence and management of skin toxicities caused by targeted therapies. Annie Young, from the University of Warwick, in Coventry, UK, poses questions arising during the e-grandround live presentation......
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.